Cargando…
Efficacy of intra‐arterial thrombolytic therapy for vision loss resulting from hyaluronic acid filler embolization
BACKGROUND: The incidence of hyaluronic acid (HA) embolism has increased markedly in recent years. HA embolism can lead to serious complications such as blindness, eye and eyelid movement disorders, skin necrosis, and cerebral embolism. However, there is a lack of robust clinical evidence regarding...
Autores principales: | Xu, Xiao, Zhou, Guiwen, Fu, Qiang, Zhang, Lixia, Yu, Youtao, Dong, Ying, Liang, Liming, Chen, Minliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596545/ https://www.ncbi.nlm.nih.gov/pubmed/33825341 http://dx.doi.org/10.1111/jocd.14111 |
Ejemplares similares
-
An expert consensus report on the clinical use of the Vycross(®) hyaluronic acid VYC‐25 L filler
por: Segurado, María A., et al.
Publicado: (2021) -
Colouring books for adults on the cancer ward
por: Rigby, Miriam, et al.
Publicado: (2016) -
COVID-19 should be recognized as an occupational disease worldwide
por: Moen, Bente E
Publicado: (2020) -
Superselective Ophthalmic Artery Thrombolytic Therapy for Hyaluronic Acid Embolization: A Case Report
por: Wu, Qian, et al.
Publicado: (2022) -
“The Perio-Diabetes Symposium”: Consensus Report of the Indian Society of Periodontology and Research Society for the Study of Diabetes in India - A joint event on Periodontitis and Diabetes
por: Dhir, Sangeeta, et al.
Publicado: (2019)